tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Phio Pharmaceuticals (PHIO)
NASDAQ:PHIO
US Market
PHIO
Phio Pharmaceuticals
RESEARCH TOOLSreports

Phio Pharmaceuticals (PHIO) Stock News & Sentiment

Compare
646 Followers
Buy Rating on PHIO: Strong Early PH-762 Clinical Data and Solid Cash Runway Support Upside Potential
Premium
Ratings
Buy Rating on PHIO: Strong Early PH-762 Clinical Data and Solid Cash Runway Support Upside Potential
15d ago
PHIO
Phio Pharmaceuticals Boosts CEO Severance and Incentive Compensation
Premium
Company Announcements
Phio Pharmaceuticals Boosts CEO Severance and Incentive Compensation
1M ago
8K
PHIO
Phio Pharmaceuticals Reports Positive PH-762 Phase 1b Safety Results
Premium
Company Announcements
Phio Pharmaceuticals Reports Positive PH-762 Phase 1b Safety Results
1M ago
8K
PHIO
Buy Rating on Phio Pharmaceuticals: Early PH-762 Efficacy, Clean Safety Profile, and Solid Cash Runway Support Favorable Risk–Reward
Premium
Ratings
Buy Rating on Phio Pharmaceuticals: Early PH-762 Efficacy, Clean Safety Profile, and Solid Cash Runway Support Favorable Risk–Reward
2M ago
PHIO
Phio Reports Positive Phase 1b PH-762 Skin Cancer Data
Premium
Company Announcements
Phio Reports Positive Phase 1b PH-762 Skin Cancer Data
2M ago
8K
PHIO
Phio Advances PH-762 With FDA-Backed Toxicology Study
Premium
Company Announcements
Phio Advances PH-762 With FDA-Backed Toxicology Study
3M ago
8K
PHIO
Phio Pharmaceuticals Completes Enrollment for PH-762 Trial
Premium
Company Announcements
Phio Pharmaceuticals Completes Enrollment for PH-762 Trial
4M ago
8K
PHIO
More PHIO News >

PHIO News on the Web

Buy Rating on PHIO: Strong Early PH-762 Clinical Data and Solid Cash Runway Support Upside Potential
TipRanks News
Bullish
PHIO’s PH-762 Posts Strong Safety Results and High Response Rate in Skin Cancer Trial—What Does This Mean for the Future?
Market Chameleon
Neutral
Analysts Offer Insights on Healthcare Companies: Phio Pharmaceuticals (PHIO) and Cabaletta Bio (CABA)
TipRanks News
Bullish
Phio Pharmaceuticals Reports Positive PH-762 Phase 1b Safety Results
TipRanks News
Neutral
PHIO Phase 1b Trial: Positive Safety Findings and 85% Response Rate Highlight Potential of PH-762 in Skin Cancer
Market Chameleon
Bullish
Phio To Commence A Toxicology Study For PH-762; Initiatives Underway For A Viable Product In 2026
rttnews
Neutral
PHIO’s Board Gets a Major Boost with New Lead Independent Director—What Does Deming’s Appointment Mean for Its Cancer Gene Silencing Ambitions?
Market Chameleon
Neutral
PHIO’s PH-762 Trial Hits Maximum Dose with Positive Responses: Complete Tumor Clearance Observed in Skin Cancer Patients
Market Chameleon
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is PHIO’s Media Buzz Sentiment?
Currently, no data Available
What is PHIO’s weekly average amount of articles?
Currently, no data Available
What is PHIO’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
KHTRFKnight Therapeutics
ABOSAcumen Pharmaceuticals
KMTSKestra Medical Technologies Ltd.
MISTMilestone Pharmaceuticals
OVIDOvid Therapeutics
Showing the stocks with the most bullish news sentiment over the past week